ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,121.24
-0.28%
Dow Jones
37,903.29
0.23%
Gold vs US Dollar
2,321.365
-0.12%
Brent Oil
83.755
0.26%
Bitcoin
57,457.22
-1.33%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Verseon (DI) (VSN)

  7. Verseon (DI) (VSN) News

Verseon (VSN)

Verseon (DI)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:VSN
DateTimeSourceHeadlineSymbolCompany
30/04/201907:02RNS Non-RegulatoryVerseon Corporation Verseon presents DME candidate at ARVO 2019LSE:VSNVerseon (DI)
18/03/201907:01UK RegulatoryVerseon Corporation Verseon announces security token offeringLSE:VSNVerseon (DI)
15/03/201912:00UK RegulatoryVerseon Corporation Change of TIDMLSE:VSNVerseon (DI)
04/03/201907:01UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
11/02/201907:00RNS Non-RegulatoryVerseon Corporation Verseon presents low bleed PROACs at ISC 2019LSE:VSNVerseon (DI)
04/02/201913:17Alliance NewsAlliance NewsVerseon Starts Dosing In Phase I Clinical Trial Of VE‑1902LSE:VSNVerseon (DI)
04/02/201907:00RNS Non-RegulatoryVerseon Corporation First participant dosed in Verseon clinical trialLSE:VSNVerseon (DI)
29/01/201912:33Alliance NewsAlliance NewsFormer LSE Chief Rolet Stands Down From Verseon Board For CQS CEO RoleLSE:VSNVerseon (DI)
29/01/201907:00UK RegulatoryVerseon Corporation Directorate ChangeLSE:VSNVerseon (DI)
08/01/201912:00UK RegulatoryVerseon Corporation Additional listing confirmationLSE:VSNVerseon (DI)
03/01/201910:20UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
27/12/201807:01UK RegulatoryVerseon Corporation Additional Listing and Total Voting RightsLSE:VSNVerseon (DI)
06/11/201812:43Alliance NewsAlliance NewsVerseon Appoints Former LSE Boss Xavier Rolet To BoardLSE:VSNVerseon (DI)
06/11/201807:00UK RegulatoryVerseon Corporation Result of AGM and changes to the BoardLSE:VSNVerseon (DI)
05/11/201807:00UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
24/10/201807:00UK RegulatoryVerseon Corporation Announcement of 2018 Annual General MeetingLSE:VSNVerseon (DI)
11/10/201812:32Alliance NewsAlliance NewsVerseon Corp Unit BlockRules Inks Blockchain Pact With NeuserenLSE:VSNVerseon (DI)
11/10/201807:00RNS Non-RegulatoryVerseon Corporation Blockchain agreement with NeuserenLSE:VSNVerseon (DI)
01/10/201808:59UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
18/09/201807:01UK RegulatoryVerseon Corporation Verseon unveils new blockchain technologyLSE:VSNVerseon (DI)
13/09/201811:36Alliance NewsAlliance NewsVerseon Corp Gets Australian Approval For Anticoagulant TrialLSE:VSNVerseon (DI)
13/09/201807:00UK RegulatoryVerseon Corporation Verseon commences anticoagulant phase I trialLSE:VSNVerseon (DI)
31/08/201807:00UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
16/08/201807:01UK RegulatoryVerseon Corporation Change of AdviserLSE:VSNVerseon (DI)
08/08/201809:45Alliance NewsAlliance NewsVerseon Interim Loss Widens As It Progresses Drug Development, TrialsLSE:VSNVerseon (DI)
08/08/201807:01UK RegulatoryVerseon Corporation Interim ResultsLSE:VSNVerseon (DI)
18/07/201813:28Alliance NewsAlliance NewsVerseon Submits Protocol For Phase One Trial Of Anticoagulant VE-1902LSE:VSNVerseon (DI)
18/07/201807:00RNS Non-RegulatoryVerseon Corporation Verseon submits phase I protocol for VE-1902LSE:VSNVerseon (DI)
06/07/201807:00UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
02/07/201807:00UK RegulatoryVerseon Corporation Additional Listing & Total Voting RightsLSE:VSNVerseon (DI)
 Showing the most relevant articles for your search:LSE:VSN

Your Recent History

LSE
GGP
Greatland Gold
LSE
VLX
Volex
LSE
BARC
Barclays
LSE
FMET
Fulcrum Metals
LSE
BIRD
Blackbird
LSE
EEE
Empire Metals
LSE
JAY
Bluejay Mining
LSE
XTR
Xtract Resources
LSE
IES
Invinity Energy Systems
LSE
EDEN
Eden Research
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved